OLANZAPINE

Product NDC
50268-615
11-digit product format
502680615
Labeler code
50268
Product ID
50268-615_d5de9d7e-79e3-5f96-e053-2995a90a3079
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
OLANZAPINE
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Labeler
AvPAK
Application
ANDA091415
Marketing category
ANDA
Marketing start
2014-04-23
Marketing end
0000-00-00
Substance
OLANZAPINE
Active strength
5 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50268-615-11EA - Each50268-615c9e906da-1623-4e1a-8c39-e163b0a35e9412015-05-05
50268-615-13EA - Each50268-615076f28c1-a706-40ab-a389-63eaacb9857c12014-09-03

DailyMed Socrata Ingredients#

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50268-615OLANZAPINE TABLET, ORALLY DISINTEGRATING [AVPAK]11Legacy NDC20250112_98697cfd-5521-f8a9-af17-555031690b08.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50268-615-135026806151330 BLISTER PACK in 1 BOX (50268-615-13) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (50268-615-11) 30 blister pack2014-04-230000-00-00NoNoCurrent